The future of medicine is based on intensive research. Innovations from genetic research and digitization, for example, are revolutionizing medicine and healthcare more than ever before. Strong entrepreneurs are also needed to turn scientists’ results into real products and help to improve patients’ diagnosis, prevention, therapy, nursing and rehabilitation. These stories provide insights into the top research and development in central Hessen and show the latest trends – always for the benefit of patients all over the world.
DFG President Prof. Dr. Katja Becker has dedicated her life as a researcher to one goal in particular: to develop new drugs and diagnostics against poverty-associated and neglected infectious diseases.
Die Deutsche Forschungsgemeinschaft (DFG) unterstützt mit 13,84 Millionen Euro ein Forschungskonsortium aus Mittelhessen, das nach neuen Strategien zur Behandlung von tödlichen und bislang unheilbaren Lungenhochdruck sucht.
Marburg-based pharmaceutical company CSL Behring is conducting intensive research on a suitable active substance against Covid-19 with the use of donated blood plasma. A globally active “Plasma Alliance” established for this purpose supports the company’s goals.